Voglimera 0.2 Tablet DT
Marketer
Numera Life Sciences
Salt Composition
Voglibose (0.2mg)
Overview Voglimera 0.2 Tablet DT
Diabetol 0.2mg tablets are prescribed for managing type 2 diabetes. They help regulate postprandial hyperglycemia (high blood sugar after meals), employed when dietary adjustments and other similar medications prove insufficient. Diabetol 0.2mg tablets should be ingested immediately before meals. Dosage and frequency are determined by your physician to optimize blood glucose control. Discontinuing treatment abruptly is unsafe and may result in elevated blood sugar, risking complications such as nephropathy and vision impairment. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Commonly reported side effects include abdominal discomfort, gas, appetite changes, constipation, and diarrhea. Report any persistent or troubling side effects to your physician. While Diabetol 0.2mg tablets alone do not typically cause hypoglycemia, concurrent use with other antidiabetic agents (particularly insulin or sulfonylureas) increases this risk. Glucose tablets are the recommended treatment for hypoglycemic episodes; sucrose is ineffective in this context. Prior to commencing treatment, inform your physician of any hepatic or renal conditions. This medication is contraindicated in patients with inflammatory bowel disease (e.g., ulcerative colitis or Crohn’s disease). Pregnant or lactating individuals should seek medical counsel before using Diabetol 0.2mg tablets. Comprehensive disclosure of all other medications is crucial for patient safety. Excessive alcohol consumption should be avoided due to the increased hypoglycemia risk.
Uses of Voglimera 0.2 Tablet DT
Managing type 2 diabetes
Major Benefits of Voglimera 0.2 Tablet DT:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Dissolve the tablet in water before ingestion. Ingest Voglimera 0.2 Tablet DT on an empty stomach.
Common Side effects of Voglimera 0.2 Tablet DT:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglimera 0.2 Tablet DT:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Always dissolve one Voglimera 0.2 Tablet DT in water before consumption. Administer on an empty stomach.
How Voglimera 0.2 Tablet DT works:
Voglimera 0.2 DT tablets are used to manage diabetes. Their mechanism involves blocking the action of intestinal enzymes that digest complex carbohydrates into simple sugars like glucose, thereby moderating postprandial blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglimera 0.2 DT tablets with alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
Pregnant individuals may generally use Voglimera 0.2 Tablet DT with safety. Animal research indicates minimal or no negative impacts on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Voglimera 0.2 Tablet DT without significant concern. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglimera 0.2 Tablet DT.
KidneyCAUTION
Patients with severe kidney impairment should use Voglimera 0.2 Tablet DT cautiously. Dosage modification for Voglimera 0.2 Tablet DT might be necessary; physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Voglimera 0.2 Tablet DT; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Voglimera 0.2 Tablet DT :
Omit any missed Voglimera 0.2 Tablet DT and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglimera 0.2 Tablet DT
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
| Actions | Alpha-glucosidase inhibitors |
3,018 People bought this recently